Implantation assembly for an iris-expanding device

Information

  • Patent Grant
  • 10537473
  • Patent Number
    10,537,473
  • Date Filed
    Wednesday, May 16, 2018
    6 years ago
  • Date Issued
    Tuesday, January 21, 2020
    4 years ago
Abstract
An iris-expanding device injector assembly is described. The iris-expanding device injector assembly has a handle, a slider and/or button coupled with the handle and configured to slide with respect to the handle, a cannula coupled with the handle, the cannula configured to slide in to and out from a holder containing an iris-expanding device, and a hook housed within the cannula.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

The present invention relates to a ring used in an ophthalmic surgical procedure.


Background Information

There are various ophthalmic procedures that require the dilation of the pupil. For example, cataracteous lenses are typically replaced in a procedure commonly referred to as phacoemulsification or phaco for short. In a phaco procedure the lens is broken up with an instrument, typically with an ultrasonically driven tool. The instrument has an aspiration port that aspirates the broken lens material from the patient's ocular chamber.


It is desirable to extend the pupil during a phaco procedure to provide the surgeon with a wide view of the lens. One technique for extending the pupil includes pulling back the iris with a series of plastic hooks. It is has been found that using plastic hooks can cause damage to iris tissue.


SUMMARY OF THE INVENTION

A ring used to maintain a pupil in an extended position during an ophthalmic procedure. The ring has a plurality of loops.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing will be apparent from the following more particular description of example embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments of the present invention.



FIG. 1 is an illustration of a ring of the present invention;



FIG. 2 is an illustration showing an enlarged view of the ring;



FIG. 3 is an illustration showing iris tissue being inserted into a first loop of the ring;



FIG. 4 is an illustration showing iris tissue being inserted into a second loop of the ring;



FIG. 5 is an illustration showing the iris tissue within gaps of the loops;



FIG. 6 is an illustration showing a pupil being maintained in an extended position by the ring;



FIG. 7 is a perspective view of an injector and ring plate used to load and inject the ring.





DETAILED DESCRIPTION OF THE INVENTION

A description of example embodiments of the invention follows.


Described is a ring that can maintain a pupil in an extended position during an ophthalmic procedure. The ring has a plurality of loops that capture iris tissue. The ring is configured to extend the pupil when iris tissue is inserted into each loop. An ophthalmic procedure such as phacoemulsification can then be performed on the patient. The ring has a center opening that provides a wide view of the ocular chamber during the procedure.


Referring to the drawings more particularly by reference numbers, FIG. 1 shows an embodiment of a ring 10 that can be used to extend a pupil during an ophthalmic procedure. The ring 10 has a plurality of loops 12, 14, 16 and 18 located at the corners of four sides 20, 22, 24 and 26. Each loop 12, 14, 16 and 18 may be formed by one full turn. Although one full turn is shown and described, it is to be understood that each loop 12, 14, 16 and 18 may have multiple turns. The four sides 20, 22, 24 and 26 circumscribe a center opening 28.


The ring 10 preferably has a square configuration such that the sides 20, 22, 24 and 26 are of equal dimension. Although a square ring is shown and described, it is to be understood that the ring may have a rectangular configuration where all sides 20, 22, 24 and 26 are not of equal dimension. Additionally, the ring may have a nonrectangular shape. For example, the ring 10 may be shaped as a triangle that has three sides and three loops located at the ring corners. Although three and four sided rings have been described, it is to be understood that the ring may have any number of side and loops. The ring 10 is preferably constructed from a molded plastic material, although it is to be understood that other materials such as metal or plastic coated metal may be employed.



FIG. 2 shows a preferred embodiment for constructing the ring 10. One side 20 of the ring 10 has two ends 30 and 32 that are butt attached by an adhesive 34. Each end 30 and 32 may have an indent 36 and 38, respectively. The adhesive 34 can flow into the indents 36 and 38 to increase the strength of the butt attachment of the ring 10. The indents 36 and 38 create surface structure that minimizes shearing and de-lamination of the adhesive 34 from the ring 10. By way of example, the adhesive 34 may be a biocompatible material such as Class VI epoxy. The adhesive 34 can be applied with a tool (not shown) that insures a repeatable volume and dimensions of the solidified adhesive form.



FIG. 3 shows the initial stages of the ring 10 being inserted into a patient's eye 50 to stretch the iris 52 and extend the pupil 54. A tool such as a forcep (not shown) can be used to pull the iris so that iris tissue is inserted into loop 14 of the ring 10. As shown in FIG. 4, the ring 10 can be manipulated so that iris tissue is inserted into loops 12 and 16.


As shown in FIG. 1, an example of the device of the present invention is a polygonal ring formed from a single strand. As shown in FIG. 5 each loop 12, 16, etc. has a gap 58 that receives and captures iris tissue. The gap is wedge-shaped and faces the periphery of the ring 10. It is formed between a top portion of the strand and a bottom portion of the strand. The loop design provides an easy means of inserting and capturing iris tissue. The flexibility of the ring 10 allows the loops to deflect and apply a clamping force onto the iris tissue. The clamping force assists in maintaining the position of the ring relative to the eye.


As shown in FIG. 6 iris tissue can be inserted into the second 14 and fourth 18 loops to fully stretch the iris 52 and extend the pupil 54. An ophthalmic procedure can then be performed on the eye. For example, a phaco procedure can be performed wherein the lens is emulsified and aspirated from the eye. The ring 10 maintains the pupil 54 in the fully extended position while the center opening 28 provides a wide viewing area during the procedure. When the procedure is complete one of the sides 20, 22, 24 or 26 can be cut with an instrument and the ring 10 can be removed from the eye.



FIG. 7 shows an embodiment of an injector 100 that can be used to inject a ring 10 into a patient's eye. The ring 10 can be loaded into the injector with the use of a ring plate 102. The ring plate 102 may include a cover 104 that is attached to a base plate 106 by fasteners 108. The base plate 106 has a channel 110 and a recess 112. The recess 112 receives the ring 10.


The injector 100 includes a cannula 120 attached to a handle 122, the handle 122 having a tapered shape configured to couple with the holder. Within the cannula 120 is a wire hook 124. The wire hook 124 is connected to an inner slide tube 126 located within the handle 122, the inner slide tube 126 having a track. A button 128 is attached to the inner slide tube 126. The injector 100 may also have a pair of guide pins 130 that are attached to the handle 122 and cooperate with corresponding channel features 132 of the base plate 106 to properly align the injector 100 when the cannula 120 is inserted into the base plate channel 110.


In operation, the cannula 120 is inserted into the base plate channel 110. When fully inserted, the wire hook 124 extends to approximately the center of the ring 10. The cover 104 may have an opening 134 that allows an operator to visually see the hook 124 within the ring opening. An operator can pull the button 128 in the direction indicated by the arrow. Pulling the button 128 causes the hook 124 to grasp the ring loops and pull the ring 10 into the cannula 120. The recess 112 has tapered walls 136 to assist in the ring collapsing within the channel 110 for insertion into the cannula 120. Once loaded, the ring 10 can be injected into a patient's eye by pushing the button 128 in the opposite direction.


While certain exemplary embodiments have been described and shown in the accompanying drawings, it is to be understood that such embodiments are merely illustrative of and not restrictive on the broad invention, and that this invention not be limited to the specific constructions and arrangements shown and described, since various other modifications may occur to those ordinarily skilled in the art.

Claims
  • 1. An iris-expanding device injector assembly comprising: a handle having a first end, a second end, an interior, and a length;a slider coupled with the handle and configured to slide with respect to the handle;a cannula coupled with the first end of the handle and having an open end spaced from the first end of the handle, the cannula configured to slide in to and out from a holder containing an iris-expanding device;a hook connected to the slider, the hook configured to: extend into the holder in response to sliding the slider in a first direction;grasp the iris-expanding device contained in the holder, wherein the iris-expanding device is contained in the holder in an expanded configuration; andpull the iris-expanding device into the open end of the cannula in response to sliding the slider in a second direction,wherein pulling the iris-expanding device into the open end of the cannula causes the iris-expanding device to transition from the expanded configuration to a collapsed configuration in the cannula.
  • 2. The iris-expanding device injector assembly of claim 1, wherein the cannula has a top surface and a bottom surface, and wherein the bottom surface of the cannula extends beyond the top surface of the cannula at the open end of the cannula.
  • 3. The iris-expanding device injector assembly of claim 1, wherein the handle further comprises a top end and a bottom end, and wherein the top end comprises a groove configured to receive the slider.
  • 4. The iris-expanding device injector assembly of claim 1, wherein the handle further comprises a first alignment pin extending from the handle in a first direction outward from the length of the cannula.
  • 5. The iris-expanding device injector assembly of claim 4, wherein the handle further comprises a second alignment pin extending from the handle in a second direction outward from the length of the cannula.
  • 6. The iris-expanding device injector assembly of claim 1, wherein the handle further comprises a track disposed within the interior of the handle, and wherein the slider is configured to slide along the track.
  • 7. The iris-expanding device injector assembly of claim 1, wherein, when the iris-expanding device is in the collapsed configuration within the cannula, moving the slider in the first direction causes the hook to extend past the open end of the cannula, thereby ejecting the iris-expanding device into the expanded configuration outside of the cannula.
  • 8. The iris-expanding device injector assembly of claim 1, wherein the first end of the handle has a tapered shape configured to couple with the holder.
  • 9. An iris-expanding ring injector comprising: a handle having a distal end, a proximal end, an interior;a button coupled to the handle and configured to move between a first position and a second position;a cannula having: a proximal end coupled to the distal end of the handle, andan open distal end;a hook housed within the cannula when the button is in the first position,wherein, when the button is moved to the second position, the hook extends past the open distal end of the cannula, and is configured to grasp an iris-expanding ring in an expanded configuration, andwherein, when the button is moved to the first position, the iris-expanding ring grasped by the hook is transitioned from the expanded configuration into a collapsed configuration in the cannula.
  • 10. The iris-expanding ring injector of claim 9, wherein the handle comprises a track disposed within the interior of the handle, and wherein the button is configured to slide along the track between the first position and the second position.
  • 11. The iris-expanding ring injector of claim 9, wherein the handle further comprises a top end and a bottom end, and wherein the top end of the handle includes a groove configured to guide the button between the first position and the second position.
  • 12. The iris-expanding ring injector of claim 9, wherein the open distal end of the cannula comprises a top surface and a bottom surface, and wherein the bottom surface of the cannula extends beyond the top surface of the cannula at the open distal end of the cannula.
  • 13. The iris-expanding ring injector of claim 9, wherein, when the iris-expanding ring is in the collapsed configuration within the cannula, moving the button from the first position to the second position causes the hook to extend toward the open distal end of the cannula, thereby ejecting the iris-expanding ring from the cannula into the expanded configuration.
  • 14. An iris-expanding device injector assembly comprising: a handle having a distal end, a proximal end, an interior, and a length;a slider configured to move between the distal end and the proximal end of the handle;a cannula having: a proximal end coupled to the distal end of the handle, andan open distal end;an arm having a contacting end that contacts an iris-expanding device, wherein the arm and the contacting end are housed within the cannula when the slider is in a first position towards the proximal end of the handle,wherein, when the arm and the contacting end are housed within the cannula, the iris-expanding device is in a collapsed configuration in the cannula, andwherein, when the slider is moved to a second position towards the distal end of the handle, the contacting end of the arm extends beyond the open distal end of the cannula and transfers the iris-expanding device in the collapsed configuration beyond the open distal end of the cannula into an expanded configuration.
  • 15. The iris-expanding device injector of claim 14, wherein the interior of the handle comprises a track, and wherein the track is configured to guide the slider.
  • 16. The iris-expanding device injector of claim 14, wherein the handle further comprises a top end and a bottom end, wherein the top end of the handle includes a groove configured to guide the slider between the distal end and the proximal end of the handle.
  • 17. The iris-expanding device injector of claim 14, wherein the open distal end of the cannula comprises a top surface and a bottom surface, and wherein the bottom surface of the open distal end of the cannula extends beyond the top surface of the open distal end of the cannula.
  • 18. The iris-expanding device injector assembly of claim 14, wherein the handle further comprises a first alignment pin extending from the handle in a first direction outward from the length of the cannula.
  • 19. The iris-expanding device injector assembly of claim 18, wherein the handle further comprises a second alignment pin extending from the handle in a second direction outward from the length of the cannula.
  • 20. The iris-expanding device injector assembly of claim 14, wherein the contacting end of the arm that contacts the iris-expanding device comprises a grasping end that grasps the iris-expanding device.
RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/648,360 filed on Jul. 12, 2017, now U.S. Pat. No. 9,980,852 issued May 29, 2018, which is a continuation of Ser. No. 13/661,982 filed Oct. 26, 2012, which is a continuation of U.S. application Ser. No. 12/074,742, filed Mar. 5, 2008, now U.S. Pat. No. 8,323,296 issued Dec. 4, 2012, which claims the benefit of U.S. Provisional Application No. 60/918,405 filed on Mar. 15, 2007. The entire teachings of the above application(s) are incorporated herein by reference.

US Referenced Citations (74)
Number Name Date Kind
1506186 Owen et al. Aug 1924 A
2761457 Wood Sep 1956 A
3975779 Richards et al. Aug 1976 A
4203168 Rainin et al. May 1980 A
4321916 McKee Mar 1982 A
4387706 Glass Jun 1983 A
4412532 Anthony Nov 1983 A
4446582 Hanna May 1984 A
4782820 Woods Nov 1988 A
4991567 McCuen et al. Feb 1991 A
5163419 Goldman Nov 1992 A
5267553 Graether Dec 1993 A
5299564 Sabatino Apr 1994 A
5318011 Federman et al. Jun 1994 A
5322054 Graether Jun 1994 A
5334217 Das Aug 1994 A
5374272 Arpa et al. Dec 1994 A
5427088 Graether Jun 1995 A
5441045 Federman Aug 1995 A
5456274 Selbee et al. Oct 1995 A
5489295 Piplani et al. Feb 1996 A
5634884 Graether Jun 1997 A
5693085 Buirge et al. Dec 1997 A
5951565 Freeman Sep 1999 A
6068643 Milverton May 2000 A
6200336 Pavcnik et al. Mar 2001 B1
6231583 Lee May 2001 B1
6332866 Grieshaber Dec 2001 B1
6497724 Stevens et al. Dec 2002 B1
6620098 Milverton Sep 2003 B1
6814748 Baker et al. Nov 2004 B1
7305996 Kraft et al. Dec 2007 B2
7412993 Tzeng Aug 2008 B2
7985180 Brown Jul 2011 B2
8257256 Krolman Sep 2012 B1
8323296 Malyugin Dec 2012 B2
8376743 Bukhary Feb 2013 B1
8439833 Christensen May 2013 B2
8496583 Reynard Jul 2013 B1
8900136 Cote et al. Dec 2014 B2
9089397 Clarke Jul 2015 B2
9504459 Nallakrishnan Nov 2016 B1
9763653 Malyugin Sep 2017 B2
9917710 Malyugin et al. Mar 2018 B2
9918710 Malyugin et al. Mar 2018 B2
9974688 Malyugin et al. May 2018 B2
9980852 Malyugin et al. May 2018 B2
20020004676 Wallace Jan 2002 A1
20020120277 Hauschild Aug 2002 A1
20030092970 Lee May 2003 A1
20050192606 Paul et al. Sep 2005 A1
20070239141 Hartley Oct 2007 A1
20080108879 Brown May 2008 A1
20080243139 Dusek Oct 2008 A1
20080262592 Jordan Oct 2008 A1
20080269888 Malyugin Oct 2008 A1
20080275461 Nallakrishnan Nov 2008 A1
20090259260 Bentley Oct 2009 A1
20100274257 Neusidl Oct 2010 A1
20120136322 Alster et al. May 2012 A1
20120289786 Dusek Nov 2012 A1
20130053860 Malyugin Feb 2013 A1
20130096386 Christensen et al. Apr 2013 A1
20130131458 Malugin et al. May 2013 A1
20130267988 Sussman et al. Oct 2013 A1
20130331939 Stevens Dec 2013 A1
20140221759 Mackool et al. Aug 2014 A1
20140378773 Dykes Dec 2014 A1
20150164685 Bhattacharjee Jun 2015 A1
20150265269 Malyugin Sep 2015 A1
20170265851 Kahook et al. Sep 2017 A1
20170312126 Malyugin et al. Nov 2017 A1
20170312127 Malyugin et al. Nov 2017 A1
20180303474 Malyugin et al. Oct 2018 A1
Foreign Referenced Citations (7)
Number Date Country
93 20 127 Apr 1994 DE
14506 Feb 2000 RU
14505 Sep 2000 RU
WO 9515120 Jun 1995 WO
WO 0032141 Jun 2000 WO
WO 2008115454 Sep 2008 WO
WO 2008115455 Sep 2008 WO
Non-Patent Literature Citations (4)
Entry
Cimberle, M., “New Pupil Expander Easier to Implant, Gentle on the Iris,” Ocular Surgery News Europe Asia Edition, [online], May 2006 [retrieved on Mar. 27, 2013]. Retrieved from the Internet URL: hap://www.osasupersite.com/view.aspx?rid-16863.
He et al, “Distribution and Heritability of Iris Thickness and Pupil Size in Chinese: The Guangzhou Twin Eye Study”, Apr. 2009, IOVS ARVO Journal, vol. 50, Issue 4, pp. 1593-1597.
Written Opinion of the International Searching Authority dated Jul. 23, 2008 for International Application No. PCT/US2008/003472, entitled “Ring Used in a Small Pupil Phacoemulsification Procedure”.
International Preliminary Report on Patentability dated Sep. 15, 2009 for International Application No. PCT/US2008/003472,entitled “Ring Used in a Small Pupil Phacoemulsification Procedure”.
Related Publications (1)
Number Date Country
20180333301 A1 Nov 2018 US
Provisional Applications (1)
Number Date Country
60918405 Mar 2007 US
Continuations (3)
Number Date Country
Parent 15648360 Jul 2017 US
Child 15981639 US
Parent 13661982 Oct 2012 US
Child 15648360 US
Parent 12074742 Mar 2008 US
Child 13661982 US